How information about side effects affects ADHD medication in children
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether the way side effects are explained to children and parents affects how many side effects are reported. It may help children aged 7 to 17 who are starting ADHD medication for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 7 and 17 years old.
- You must have been recently diagnosed with ADHD or ADD by a psychologist.
- Both you and your parents must want to start ADHD medication.
- You must not have taken stimulant medication for ADHD before.
- No one in your immediate family (parents, siblings, or grandparents) has used stimulants for ADHD in the last two years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This study looks at how ADHD medications and small head movements during brain scans affect attention. It may help researchers understand how these medicines work, which could improve ADHD care.
This study tests a new computer-based tool that helps doctors diagnose ADHD in children aged 6 to 12. It looks at how well and how safely the tool works compared to standard evaluations, and it may help your child get a faster, clearer diagnosis.
This study looks at how mental effort affects children and teens with ADHD. It may help doctors understand ADHD better and improve care.
This Phase 2 study compares two ADHD medicines—lisdexamfetamine and methylphenidate—in children who have ADHD and type 1 diabetes. It’s designed to see which option works better and is safe/effective for managing ADHD without causing major problems for diabetes care.
Hear when a new Attention Deficit Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.